Advanced NSCLC: new cytostatic agents

Lung Cancer. 2003 Aug:41 Suppl 1:S123-32. doi: 10.1016/s0169-5002(03)00156-9.

Abstract

There are several new cytostatic agents under investigation for the treatment of advanced non-small cell lung cancer either as first or second-line. In this review we will present the current information about oxaliplatin, epothilones, irinotecan and alimta.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Camptothecin / analogs & derivatives*
  • Camptothecin / pharmacology*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Clinical Trials as Topic
  • Epothilones / pharmacology*
  • Glutamates
  • Guanine / analogs & derivatives*
  • Humans
  • Irinotecan
  • Lung Neoplasms / drug therapy*
  • Organoplatinum Compounds / pharmacology*
  • Oxaliplatin
  • Pemetrexed
  • Thymidylate Synthase / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • Epothilones
  • Glutamates
  • Organoplatinum Compounds
  • Pemetrexed
  • Oxaliplatin
  • Guanine
  • Irinotecan
  • Thymidylate Synthase
  • Camptothecin